A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control
- PMID: 33671684
- PMCID: PMC7926438
- DOI: 10.3390/pathogens10020248
A Review of Streptococcus pyogenes: Public Health Risk Factors, Prevention and Control
Abstract
Streptococcus pyogenes, (colloquially named "group A streptococcus" (GAS)), is a pathogen of public health significance, infecting 18.1 million people worldwide and resulting in 500,000 deaths each year. This review identified published articles on the risk factors and public health prevention and control strategies for mitigating GAS diseases. The pathogen causing GAS diseases is commonly transmitted via respiratory droplets, touching skin sores caused by GAS or through contact with contaminated material or equipment. Foodborne transmission is also possible, although there is need for further research to quantify this route of infection. It was found that GAS diseases are highly prevalent in developing countries, and among indigenous populations and low socioeconomic areas in developed countries. Children, the immunocompromised and the elderly are at the greatest risk of S. pyogenes infections and the associated sequelae, with transmission rates being higher in schools, kindergartens, hospitals and residential care homes. This was attributed to overcrowding and the higher level of social contact in these settings. Prevention and control measures should target the improvement of living conditions, and personal and hand hygiene. Adherence to infection prevention and control practices should be emphasized in high-risk settings. Resource distribution by governments, especially in developed countries, should also be considered.
Keywords: GAS; Strep A; group A strep; group A streptococcus; infection control; management; policy; risk assessment; streptococcus pyogenes.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
-
Streptococcus pyogenes adhesion and colonization.FEBS Lett. 2016 Nov;590(21):3739-3757. doi: 10.1002/1873-3468.12254. Epub 2016 Jul 1. FEBS Lett. 2016. PMID: 27312939 Review.
-
Epidemiology of Streptococcus pyogenes.2016 Feb 10 [updated 2017 Apr 3]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. 2016 Feb 10 [updated 2017 Apr 3]. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. PMID: 26866237 Free Books & Documents. Review.
-
Asymptomatic throat carriage rate and antimicrobial resistance pattern of Streptococcus pyogenes in Nepalese school children.Kathmandu Univ Med J (KUMJ). 2009 Oct-Dec;7(28):392-6. doi: 10.3126/kumj.v7i4.2760. Kathmandu Univ Med J (KUMJ). 2009. PMID: 20502080
-
Identification of Tuberculosis: A Review of the Guidelines [Internet].Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 6. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Feb 6. PMID: 33074601 Free Books & Documents. Review.
Cited by
-
Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes.Drugs R D. 2024 Mar 18. doi: 10.1007/s40268-024-00452-y. Online ahead of print. Drugs R D. 2024. PMID: 38494581
-
Invasive group A streptococcal (iGAS) surveillance in Island Health, British Columbia, 2022.Can Commun Dis Rep. 2023 Aug 1;49(7-8):342-350. doi: 10.14745/ccdr.v49i78a06. eCollection 2023 Aug 1. Can Commun Dis Rep. 2023. PMID: 38455877 Free PMC article.
-
Alginate and Chitosan-Based Hydrogel Enhance Antibacterial Agent Activity on Topical Application.Infect Drug Resist. 2024 Mar 1;17:791-805. doi: 10.2147/IDR.S456403. eCollection 2024. Infect Drug Resist. 2024. PMID: 38444772 Free PMC article. Review.
-
Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.Immunol Res. 2024 Feb 21. doi: 10.1007/s12026-024-09456-x. Online ahead of print. Immunol Res. 2024. PMID: 38383811
-
Outbreak of severe community-acquired bacterial infections among children in North Rhine-Westphalia (Germany), October to December 2022.Infection. 2024 Feb 16. doi: 10.1007/s15010-023-02165-x. Online ahead of print. Infection. 2024. PMID: 38366304
References
-
- Kimberlin D.W., Brady M.T., Jackson M.A. Group A Streptococcal Infections. American Academy of Pediatrics; Itasca, IL, USA: 2015. pp. 732–744.
-
- World Health Organization . The Current Evidence for the Burden of Group A Streptococcal Diseases. World Health Organization; Geneva, Switzerland: 2005.
-
- Ralph A.P., Carapetis J.R. Host-Pathogen Interactions in Streptococcal Diseases. Springer; Berlin/Heidelberg, Germany: 2012. Group A streptococcal diseases and their global burden; pp. 1–27. - PubMed
-
- Tagini F., Aubert B., Troillet N., Pillonel T., Praz G., Crisinel P., Prod’hom G., Asner S., Greub G. Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: Analysis of a case series of invasive Streptococcus pyogenes infections. Eur. J. Clin. Microbiol. Infect. Dis. 2017;36:1173–1180. doi: 10.1007/s10096-017-2905-z. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
